NURS 5663 PHARM WEEKLY QUIZZES | WEEK 1-
6 | COMPREHENSIVE PRACTICE EXAMINATION
| 2026 UPDATE | QUESTIONS AND ANSWERS
WITH RATIONALES | 100% CORRECT | TEXAS
WOMAN'S UNIVERSITY
This comprehensive practice examination is meticulously designed for students preparing for the
NURS 5663 Pharmacotherapeutics for Advanced Nursing Practice Weekly Quizzes at Texas
Woman's University (TWU). Aligned with the 2026 curriculum, this document features 100
questions that mirror the complexity and rigor of the actual weekly quizzes. It covers all essential
domains across Weeks 1-6, including basic pharmacology principles, pharmacokinetics,
pharmacodynamics, autonomic nervous system pharmacology, cardiovascular pharmacology,
psychopharmacology, pain management, anti-infectives, endocrine pharmacology, and
geriatric/pediatric considerations. Each question is accompanied by a detailed, verified solution
and clinical rationale to ensure 100% correct answers and a deep, integrated understanding of
pharmacotherapeutics principles, guaranteeing distinction-level preparation for this critical
nursing credential.
TABLE OF CONTENTS
1. Basic Pharmacology Principles & Pharmacokinetics (Weeks 1-2) (Questions 1-30)
2. Pharmacodynamics & Autonomic Nervous System (Week 2-3) (Questions 31-50)
3. Cardiovascular, Anti-infective & Endocrine Pharmacology (Weeks 3-4) (Questions 51-70)
4. Psychopharmacology, Pain & Anti-inflammatory (Weeks 4-5) (Questions 71-90)
5. Geriatric, Pediatric & Special Population Considerations (Weeks 5-6) (Questions 91-100)
,SECTION 1: BASIC PHARMACOLOGY PRINCIPLES & PHARMACOKINETICS
(WEEKS 1-2)
Question 1
Which of the following best describes the cytochrome P450 system?
A) A series of enzymes used to synthesize medications
B) A series of enzymes used to metabolize medications
C) A transport system for moving drugs across cell membranes
D) A receptor system that triggers drug excretion
Correct Answer: B
The cytochrome P450 system is a series of enzymes primarily located in the liver that metabolize
medications, transforming them into more water-soluble compounds for excretion. CYP450
enzymes are responsible for the metabolism of many drugs, and variations in their activity can
significantly affect drug efficacy and toxicity.
Question 2
What is the effect of CYP450 enzyme inhibitors on drug metabolism?
A) They increase enzyme activity and accelerate drug metabolism
B) They block metabolic activity from one or more CYP450 enzymes
C) They have no effect on drug metabolism
D) They enhance drug absorption from the gut
Correct Answer: B
Inhibitors block metabolic activity from one or more CYP450 enzymes, leading to decreased
metabolism of drugs and potentially increased drug levels and toxicity. Cimetidine is a classic
example of a potent CYP450 inhibitor that can reduce the metabolism of drugs like warfarin,
phenytoin, and theophylline.
Question 3
What is the effect of CYP450 enzyme inducers on drug metabolism?
A) They decrease enzyme activity and slow drug metabolism
B) They have no effect on drug metabolism
C) They increase enzyme activity and accelerate drug metabolism
D) They block drug absorption from the gut
Correct Answer: C
Inducers increase the activity of CYP450 enzymes, leading to accelerated metabolism of drugs
and potentially decreased drug levels and reduced therapeutic effects. This can necessitate
higher doses of medications to achieve the desired effect.
,Question 4
A drug has a half-life of 12 hours. How many half-lives are required to reach steady state?
A) 1-2
B) 3-5
C) 6-8
D) 10-12
Correct Answer: B
Steady state is achieved after approximately 4-5 half-lives (usually 3-5). For a 12-hour half-life,
steady state is reached in 48-60 hours. Two half-lives reach 75% of steady state, while four to
five half-lives reach 94-97% of steady state.
Question 5
A patient reports that Brand X tablets work faster than Brand Y tablets of the same amount of the
same drug. Which statement informs the prescriber's response?
A) Inactive ingredients used in composition can result in differing rates of dissolution, which can
alter the drug's onset of action
B) Because the drug preparations are chemically equivalent, the actions of the two brands must
be identical
C) Advertising by pharmaceutical companies can enhance patient expectations of one brand over
another
D) The bioavailability of a drug is determined by the amount of the drug in each dose
Correct Answer: A
Even if two brands of a drug are chemically equivalent (identical amounts of the same chemical
compound), they can have different effects if they differ in bioavailability. Tablets made by
different manufacturers contain different binders and fillers, which disintegrate and dissolve at
different rates, affecting the drug's bioavailability.
Question 6
A patient reports that a medication no longer effectively alleviates symptoms. What process
informs the provider's response?
A) Additional receptor sites are synthesized in response to the medication
B) Desensitization of receptor sites results from continual exposure to the drug
C) Decreased selectivity for receptors results in a variety of effects
D) Endogenous antagonists compete with the drug for receptor sites
Correct Answer: B
Continual exposure to an agonist causes the cell to become less responsive or desensitized. The
body does not produce antagonists as a response to medication. Medication tolerance is not
related to receptor selectivity, and medications do not cause more receptors to be produced.
, Question 7
The slow-acetylator phenotype is associated with:
A) Slow drug metabolism and high blood drug levels
B) Rapid drug metabolism and low blood drug levels
C) Rapid drug metabolism and high blood drug levels
D) Slow drug metabolism and low blood drug levels
Correct Answer: A
The slow-acetylator phenotype results in slower metabolism of drugs via acetylation, leading to
higher blood drug levels and increased risk of drug toxicity. This genetic variation affects drugs
like isoniazid, hydralazine, and procainamide.
Question 8
Phase 1 drug metabolizing reactions:
A) Are the only reactions which produce metabolic intermediates
B) Are conjugation reactions that add groups to enhance drug solubility and excretion
C) Always occur before Phase 2 reactions
D) Are functionalization reactions that typically involve oxidation or reduction
Correct Answer: D
Phase 1 reactions are functionalization reactions that typically involve oxidation, reduction, or
hydrolysis. These reactions introduce or expose functional groups on the drug molecule,
preparing it for Phase 2 conjugation reactions.
Question 9
What is the pharmacokinetic effect of Probenecid on the Penicillin drug class?
A) Inhibits hepatic metabolism, increasing drug levels
B) Inhibits tubular secretion in the kidney, prolonging drug action
C) Enhances glomerular filtration, decreasing drug levels
D) Competes for protein binding sites, increasing free drug levels
Correct Answer: B
Probenecid inhibits the tubular secretion of penicillin in the kidney, which prolongs the action of
penicillin by reducing its renal excretion. This allows for less frequent dosing and higher
sustained drug levels.
Question 10
Which of the following locations for genetic variations may affect drug pharmacodynamics?
A) Drug-transporter proteins
B) Drug target proteins
6 | COMPREHENSIVE PRACTICE EXAMINATION
| 2026 UPDATE | QUESTIONS AND ANSWERS
WITH RATIONALES | 100% CORRECT | TEXAS
WOMAN'S UNIVERSITY
This comprehensive practice examination is meticulously designed for students preparing for the
NURS 5663 Pharmacotherapeutics for Advanced Nursing Practice Weekly Quizzes at Texas
Woman's University (TWU). Aligned with the 2026 curriculum, this document features 100
questions that mirror the complexity and rigor of the actual weekly quizzes. It covers all essential
domains across Weeks 1-6, including basic pharmacology principles, pharmacokinetics,
pharmacodynamics, autonomic nervous system pharmacology, cardiovascular pharmacology,
psychopharmacology, pain management, anti-infectives, endocrine pharmacology, and
geriatric/pediatric considerations. Each question is accompanied by a detailed, verified solution
and clinical rationale to ensure 100% correct answers and a deep, integrated understanding of
pharmacotherapeutics principles, guaranteeing distinction-level preparation for this critical
nursing credential.
TABLE OF CONTENTS
1. Basic Pharmacology Principles & Pharmacokinetics (Weeks 1-2) (Questions 1-30)
2. Pharmacodynamics & Autonomic Nervous System (Week 2-3) (Questions 31-50)
3. Cardiovascular, Anti-infective & Endocrine Pharmacology (Weeks 3-4) (Questions 51-70)
4. Psychopharmacology, Pain & Anti-inflammatory (Weeks 4-5) (Questions 71-90)
5. Geriatric, Pediatric & Special Population Considerations (Weeks 5-6) (Questions 91-100)
,SECTION 1: BASIC PHARMACOLOGY PRINCIPLES & PHARMACOKINETICS
(WEEKS 1-2)
Question 1
Which of the following best describes the cytochrome P450 system?
A) A series of enzymes used to synthesize medications
B) A series of enzymes used to metabolize medications
C) A transport system for moving drugs across cell membranes
D) A receptor system that triggers drug excretion
Correct Answer: B
The cytochrome P450 system is a series of enzymes primarily located in the liver that metabolize
medications, transforming them into more water-soluble compounds for excretion. CYP450
enzymes are responsible for the metabolism of many drugs, and variations in their activity can
significantly affect drug efficacy and toxicity.
Question 2
What is the effect of CYP450 enzyme inhibitors on drug metabolism?
A) They increase enzyme activity and accelerate drug metabolism
B) They block metabolic activity from one or more CYP450 enzymes
C) They have no effect on drug metabolism
D) They enhance drug absorption from the gut
Correct Answer: B
Inhibitors block metabolic activity from one or more CYP450 enzymes, leading to decreased
metabolism of drugs and potentially increased drug levels and toxicity. Cimetidine is a classic
example of a potent CYP450 inhibitor that can reduce the metabolism of drugs like warfarin,
phenytoin, and theophylline.
Question 3
What is the effect of CYP450 enzyme inducers on drug metabolism?
A) They decrease enzyme activity and slow drug metabolism
B) They have no effect on drug metabolism
C) They increase enzyme activity and accelerate drug metabolism
D) They block drug absorption from the gut
Correct Answer: C
Inducers increase the activity of CYP450 enzymes, leading to accelerated metabolism of drugs
and potentially decreased drug levels and reduced therapeutic effects. This can necessitate
higher doses of medications to achieve the desired effect.
,Question 4
A drug has a half-life of 12 hours. How many half-lives are required to reach steady state?
A) 1-2
B) 3-5
C) 6-8
D) 10-12
Correct Answer: B
Steady state is achieved after approximately 4-5 half-lives (usually 3-5). For a 12-hour half-life,
steady state is reached in 48-60 hours. Two half-lives reach 75% of steady state, while four to
five half-lives reach 94-97% of steady state.
Question 5
A patient reports that Brand X tablets work faster than Brand Y tablets of the same amount of the
same drug. Which statement informs the prescriber's response?
A) Inactive ingredients used in composition can result in differing rates of dissolution, which can
alter the drug's onset of action
B) Because the drug preparations are chemically equivalent, the actions of the two brands must
be identical
C) Advertising by pharmaceutical companies can enhance patient expectations of one brand over
another
D) The bioavailability of a drug is determined by the amount of the drug in each dose
Correct Answer: A
Even if two brands of a drug are chemically equivalent (identical amounts of the same chemical
compound), they can have different effects if they differ in bioavailability. Tablets made by
different manufacturers contain different binders and fillers, which disintegrate and dissolve at
different rates, affecting the drug's bioavailability.
Question 6
A patient reports that a medication no longer effectively alleviates symptoms. What process
informs the provider's response?
A) Additional receptor sites are synthesized in response to the medication
B) Desensitization of receptor sites results from continual exposure to the drug
C) Decreased selectivity for receptors results in a variety of effects
D) Endogenous antagonists compete with the drug for receptor sites
Correct Answer: B
Continual exposure to an agonist causes the cell to become less responsive or desensitized. The
body does not produce antagonists as a response to medication. Medication tolerance is not
related to receptor selectivity, and medications do not cause more receptors to be produced.
, Question 7
The slow-acetylator phenotype is associated with:
A) Slow drug metabolism and high blood drug levels
B) Rapid drug metabolism and low blood drug levels
C) Rapid drug metabolism and high blood drug levels
D) Slow drug metabolism and low blood drug levels
Correct Answer: A
The slow-acetylator phenotype results in slower metabolism of drugs via acetylation, leading to
higher blood drug levels and increased risk of drug toxicity. This genetic variation affects drugs
like isoniazid, hydralazine, and procainamide.
Question 8
Phase 1 drug metabolizing reactions:
A) Are the only reactions which produce metabolic intermediates
B) Are conjugation reactions that add groups to enhance drug solubility and excretion
C) Always occur before Phase 2 reactions
D) Are functionalization reactions that typically involve oxidation or reduction
Correct Answer: D
Phase 1 reactions are functionalization reactions that typically involve oxidation, reduction, or
hydrolysis. These reactions introduce or expose functional groups on the drug molecule,
preparing it for Phase 2 conjugation reactions.
Question 9
What is the pharmacokinetic effect of Probenecid on the Penicillin drug class?
A) Inhibits hepatic metabolism, increasing drug levels
B) Inhibits tubular secretion in the kidney, prolonging drug action
C) Enhances glomerular filtration, decreasing drug levels
D) Competes for protein binding sites, increasing free drug levels
Correct Answer: B
Probenecid inhibits the tubular secretion of penicillin in the kidney, which prolongs the action of
penicillin by reducing its renal excretion. This allows for less frequent dosing and higher
sustained drug levels.
Question 10
Which of the following locations for genetic variations may affect drug pharmacodynamics?
A) Drug-transporter proteins
B) Drug target proteins
